Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Pramlintide approval date?What's the impact of mixing lipitor bp meds negatively?Antiox mebendazole price?Guselkumab patent expiration?Symbravo medication information ema europa eu?
See the DrugPatentWatch profile for Zerbaxa
Zerbaxa (ceftolozane and tazobactam) was approved by the U.S. FDA on February 25, 2014 [1].
Yes. Zerbaxa’s FDA labeling has been updated since the initial approval, but the original FDA approval date remains February 25, 2014 [1].
At the time of its initial FDA approval, Zerbaxa was indicated for the treatment of complicated intra-abdominal infections and complicated urinary tract infections (including pyelonephritis) in adults [1]. Sources: [1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204689
Other Questions About Zerbaxa :